Your session is about to expire
← Back to Search
Digital Memory Notebook for Cognitive Impairment (DMN Trial)
N/A
Waitlist Available
Led By Sarah Farias, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 8, and week 12
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether the Digital Memory Notebook, a tablet-based app, can help older adults with mild cognitive impairment or subjective cognitive complaints complete everyday tasks.
Who is the study for?
This trial is for English-speaking adults aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive complaints (SCC). They must have someone to help with surveys. Pregnant women, those unable to consent, and prisoners are excluded.
What is being tested?
The study tests a Digital Memory Notebook app designed to aid daily tasks for people with memory issues. It involves a 6-week training on using the app followed by a 4-week period of regular use, with assessments before and after the intervention.
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, participants may experience frustration or difficulty adapting to new technology.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1, week 8, and week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 8, and week 12
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Real-time data extracted from the DMN Application
Secondary study objectives
Participant Questionnaire Outcomes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: DMN InterventionExperimental Treatment1 Intervention
Subjects will attend 2-hour weekly sessions for 6- weeks. Participants will continue to use the DMN application for 4-weeks after the intervention is complete.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,756,120 Total Patients Enrolled
Sarah Farias, PhDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
263 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with memory problems or mild forgetfulness.You must be at least 60 years old to participate, with no upper age limit.
Research Study Groups:
This trial has the following groups:- Group 1: DMN Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Alzheimer's Disease Patient Testimony for trial: Trial Name: NCT04240665 — N/A